Advertisement
Advertisement
KOD
Kodiak Sciences Inc Common Stock
41.35
USDSponsored
+1.37
+3.43%
Aug 14, 15:59 UTC -4
Closed
After-Market
41.40
+0.05
+0.12%
KOD Earnings Reports
Positive Surprise Ratio
KOD beat 16 of 30 last estimates.
53%
Next Report
In 3 Days
Date of Next Report
Aug 19, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.96
Implied change from Q1 26 (Revenue/ EPS)
--
/+2.13%
Implied change from Q2 25 (Revenue/ EPS)
--
/-6.80%
Kodiak Sciences Inc Common Stock earnings per share and revenue
On May 07, 2026, KOD reported earnings of -0.94 USD per share (EPS) for Q1 26, beating the estimate of -1.02 USD, resulting in a 8.08% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.11% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.96 USD, with revenue projected to reach -- USD, implying an increase of 2.13% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Celcuity Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$1.18
Actual
-$1.44
Surprise
-21.23%
CorMedix Inc.
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.24
Actual
$0.28
Surprise
+19.44%
Fate Therapeutics, Inc.
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.25
Surprise
+8.49%
Caribou Biosciences, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.32
Actual
-$0.24
Surprise
+25.74%
Outlook Therapeutics, Inc. Common Stock
Report Date
Aug 14, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+5.46%
ADC Therapeutics SA
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.21
Actual
-$0.11
Surprise
+49.12%
TuHURA Biosciences, Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+5.34%
ProMIS Neurosciences Inc. Common Shares (ON)
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$1.39
Actual
-$1.28
Surprise
+8.07%
Elutia Inc. Class A Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.17
Surprise
-11.11%
Lantern Pharma Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.28
Surprise
+27.76%
FAQ
What were Kodiak Sciences Inc Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Kodiak Sciences Inc Common Stock reported EPS of -$0.94, beating estimates by 8.08%, and revenue of $0.00, 0% as expectations.
How did the market react to Kodiak Sciences Inc Common Stock's Q1 2026 earnings?
The stock price moved down -6.11%, changed from $43.68 before the earnings release to $41.01 the day after.
When is Kodiak Sciences Inc Common Stock expected to report next?
The next earning report is scheduled for Aug 19, 2026.
What are the forecasts for Kodiak Sciences Inc Common Stock's next earnings report?
Based on --
analysts, Kodiak Sciences Inc Common Stock is expected to report EPS of -$0.96 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement